Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Assets (2021 - 2025)

Historic Return on Assets for RxSight (RXST) over the last 5 years, with Q3 2025 value amounting to 0.12%.

  • RxSight's Return on Assets fell 200.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.11% for FY2024, which is 1800.0% up from last year.
  • Latest data reveals that RxSight reported Return on Assets of 0.12% as of Q3 2025, which was down 200.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, RxSight's Return on Assets registered a high of 0.04% during Q3 2021, and its lowest value of 0.44% during Q4 2022.
  • Over the past 5 years, RxSight's median Return on Assets value was 0.25% (recorded in 2021), while the average stood at 0.23%.
  • As far as peak fluctuations go, RxSight's Return on Assets tumbled by -3700bps in 2022, and later surged by 1900bps in 2024.
  • Quarter analysis of 5 years shows RxSight's Return on Assets stood at 0.25% in 2021, then tumbled by -78bps to 0.44% in 2022, then skyrocketed by 39bps to 0.27% in 2023, then surged by 67bps to 0.09% in 2024, then tumbled by -33bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.1% for Q2 2025, and 0.08% during Q1 2025.